N@N

CELG, KMB, DHR, CX, RMBS, BG Expected To Be Higher After Earnings Releases on Thursday

^{Published on 2009-10-20 10:19:00, Last Modified on 2010-12-22 17:10:30 - WOPRAI}
 

October 21, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 22nd and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and September earnings reports. Celgene (NASDAQ: CELG), Kimberly Clark (NYSE: KMB), Danaher Corp (NYSE: DHR), Cemex (NYSE: CX), Rambus (NASDAQ: RMBS) and Bunge Limited (NYSE: BG) are all expected to be higher after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher after earnings are released Thursday:

Symbol Company # of Reports Quarter Release Time

CELG Celgene Corporation 12 quarters Q3 Before

KMB Kimberly-Clark Corp October earnings Q3 Before

DHR Danaher Corporation 12 quarters Q3 Before

CX Cemex S.A.B. de C.V. October earnings Q3 After

RMBS Rambus Inc. October earnings Q3 After

BG Bunge Limited October earnings Q3 Before

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Celgene Corporation (NASDAQ: CELG) engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases primarily in Europe and the United States. Its primary commercial stage products include REVLIMID for the treatment in combination with dexamethasone for multiple myeloma patients, as well as for the treatment of patients with transfusion-dependent anemia; and THALOMID for the treatment in combination with dexamethasone of patients with newly diagnosed multiple myeloma, as well as for the treatment and suppression of cutaneous manifestations of erythema nodosum leprosum. The company also sells ALKERAN for the palliative treatment of multiple myeloma and of carcinoma of the ovary; VIDAZA, which is used for the treatment of various subtypes of MDS; RITALIN that is used for the treatment of attention deficit hyperactivity disorder; and FOCALIN for the treatment of oncology-related disorders. Its development stage products consist of CC-4047, which is in Phase II trials for the treatment of myelofibrosis and multiple myeloma, and in Phase I trials for the treatment of hemoglobinopathies; CC-10015 that is in pre-clinical stage for the treatment of inflammatory diseases; CC-10004, which is in Phase II clinical trials for the treatment of psoriasis, psoriatic arthritis, and inflammatory diseases; JNK CC-930 that is in Phase I trial to treat fibrotic diseases; Amrubicin, which is in Phase III trials for small cell lung cancer treatment; Human umbilical cord blood, a Phase I trials product to treat transplants and hematological disorders; and ACE-011, a Phase II initiated product for multiple myeloma/Bone loss treatment. Celgene Corporation has strategic collaborations with Acceleron Pharma, Inc. for the joint development and commercialization of ACE-011; and GlobeImmune Inc. to develop molecular immunotherapy for the treatment of cancer. The company was founded in 1980 and is headquartered in Summit, New Jersey.

Kimberly-Clark Corporation (NYSE: KMB), together with its subsidiaries, engages in the manufacture and marketing of health and hygiene products worldwide. The company operates in four segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. The Personal Care segment provides disposable diapers, training and youth pants, and swimpants; baby wipes; and feminine and incontinence care products, and related products. It offers its products primarily for household use under various brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, and Poise. The Consumer Tissue segment offers facial and bathroom tissue, paper towels, napkins, and related products for household use under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, and Page brands. The K-C Professional & Other segment offers facial and bathroom tissue, paper towels, napkins, wipers, and a range of safety products for the away-from-home marketplace under Kimberly-Clark, Kleenex, Scott, WypAll, Kimtech, KleenGuard, and Kimcare brand names. The Health Care segment offers disposable health care products, such as surgical gowns, drapes, infection control products, sterilization wraps, face masks, exam gloves, respiratory products, and other disposable medical products under the brand names, including Kimberly-Clark and Ballard. The company sells its products to household market, supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, retail outlets, manufacturing, lodging, office building, food service, health care establishments, and high volume public facilities. It markets its products through wholesalers, distributors, and direct sales. The company was founded in 1872 and is headquartered in Dallas, Texas.

Danaher Corporation (NYSE: DHR), together with its subsidiaries, designs, manufactures, and markets professional, medical, industrial, commercial, and consumer products, primarily in the United States, Europe, and Asia. It operates in four segments: Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools and Components. The Professional Instrumentation segment offers analytical instruments and related consumables that detect and measure chemical, physical, and microbiological parameters in drinking water, wastewater, groundwater, ocean bodies, and ultrapure water; ultraviolet disinfection systems; and chemical treatment solutions and analytical services to address corrosion, scaling, and biological growth problems in boiler, cooling water, and industrial waste water applications. This segment also provides environmental monitoring and leak detection systems; vapor recovery equipment; fuel dispensers; point-of-sale and merchandising systems; submersible turbine pumps; and remote monitoring and outsourced fuel management services. The Medical Technologies segment manufactures dental products, acute care, pathology diagnostics, and life sciences instrumentation for research and clinical medical professionals. The Industrial Technologies segment offers product identification; precision motion control equipment; aircraft and defense equipment; and sensors and controls that measure and control discrete manufacturing variables, such as temperature, position, quantity, level, flow, and time. The Tools and Components segment produces mechanicsa� hand tools, including ratchets, sockets, and wrenches, as well as specialized automotive service tools for the professional and ado-it-yourselfa� markets. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, District of Columbia.

CEMEX, S.A.B. de C.V. (NYSE: CX), through its subsidiaries, engages in the production, marketing, distribution, and sale of cement, ready-mix concrete, aggregates, and other construction materials. It sells its products primarily to distributors in the construction industry. The company has operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East, Australia, and Asia. CEMEX, S.A.B. de C.V. was founded in 1906 and is based in Garza Garcia, Mexico.

Rambus Inc. (NASDAQ: RMBS) designs, develops, and licenses chip interface technologies and architectures that are used in digital electronics products. Its products include Fully Synchronous DRAM, which is designed to allow precise timing from a DRAM system; Dual Edge Clocking that is designed to allow data to be sent on the clock pulse; Variable Burst Length, which is designed to improve data transfer efficiency by allowing varying amounts of data to be sent per a memory read or write request in DRAMs and flash memory; FlexPhase technology that synchronizes data output and compensates for circuit timing errors; and Channel Equalization, which is designed to improve signal integrity and system margins by reducing inter-symbol interference in high speed parallel and serial link channels. The company also licenses its leadership architectures and chip interfaces for use in semiconductor and system products, including XDR Memory Architecture, which enables the production of DRAM; XDR2 Memory Architecture that includes DRAM micro-threading for graphics intensive applications, such as gaming and digital video; RDRAM Memory, which is used in play stations, Intel-based personal computers, televisions, and routers; and FlexIO processor bus, a high speed chip-to-chip interface, as well as provides digital logic controllers for PCI Express, DDRx memory, and other interfaces. Its products are used in computing, gaming and graphics, and consumer electronics applications, as well as in personal computers, servers, printers, video projectors, game consoles, digital TVs, set-top boxes, and mobile phones. Rambus Inc. was founded in 1990 and is headquartered in Los Altos, California.

Bunge Limited (NYSE: BG) engages in the agriculture and food business worldwide. It operates in three divisions: Agribusiness, Fertilizer, and Food Products. The Agribusiness division purchases, stores, transports, processes, and sells agricultural commodities, including grains and oilseeds, such as soybeans, rapeseed or canola, sunflower seeds, wheat, and corn; and commodity products. It sells its products to animal feed manufacturers, wheat and corn millers, and oilseed processors; livestock, poultry, and aquaculture producers; and edible oil processing companies. The Fertilizer division produces and supplies fertilizers to farmers. It engages in nutrients and retail operations, including mining and processing phosphate ore; and the production of intermediate phosphate-based products for sale to fertilizer blenders. This divisiona�s products include phosphate rock, sulfuric acid, phosphoric acid, single super phosphate, and dicalcium phosphate, and phosphate-based animal feed ingredients. It also produces, distributes, and sells blended NPK formulas and other fertilizer products directly to retailers, processing and trading companies, and farmers. The Food Products division offers edible oil products and milling products for food processors, foodservice companies, and retail outlets. Its edible oil products include packaged and bulk oils, shortenings, margarines, mayonnaise, and other products derived from the vegetable oil refining process; and milling products comprise various wheat flours and bakery mixes, and corn-based products derived from the corn dry milling process consisting primarily of dry milled corn meal, flours, grits, soy-fortified corn meal, corn-soy blend, corn oil, and corn feed products. Bunge Limited was founded in 1818 and is headquartered in White Plains, New York.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.6 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641